Join Julius Clinical at the ENCALS Meeting 2026 in Madrid from June 24-26, 2026.

Meet our neuroscience experts at the ENCALS (European Networks to Cure ALS) Meeting 2026 to discover how Julius Clinical supports efficient, high-quality clinical trials across complex neurological and psychiatric conditions. Our team partners with sponsors to navigate the unique challenges of neuroscience drug development, delivering tailored strategies that accelerate timelines while maintaining scientific rigor.

Let’s Meet in Madrid!

Connect with our team at the ENCALS Meeting to discuss how we can support your next neuroscience clinical trial.

Name(Required)

Advancing Neuroscience Clinical Development with Confidence

Julius Clinical offers comprehensive support across all phases of clinical development. With deep expertise in central nervous system diseases, we help bring innovative therapies to patients faster. From protocol development to study execution, we provide a fully integrated approach designed to optimize outcomes at every stage.

Explore our neuroscience expertise.

Why Julius Clinical?

Neuroscience trials present distinct challenges, from complex endpoints to patient variability and recruitment barriers. Julius Clinical combines scientific expertise with operational precision to address these challenges effectively.

With our strong global network and experienced in-house teams, we deliver customized solutions aligned with your development goals, ensuring high-quality data and reliable study execution.